Popular weight-loss drugs including Ozempic, Wegovy, Saxenda, and Mounjaro (GLP-1 agonists) are linked to malnutrition, vitamin deficiencies, and scurvy due to severe appetite suppression and reduced calorie intake, per a systematic review and BMJ op-ed.
Risks encompass thiamine deficiency, Wernicke encephalopathy (potentially irreversible brain damage), low magnesium, and metabolic issues, especially in vulnerable groups.
Experts call for nutritional screening, monitoring, and caution, particularly in children.
Cases include Robbie Williams' scurvy and vision issues.